Ticker > Company >

Abbott India share price

Abbott India Ltd.

NSE: ABBOTINDIA BSE: 500488 SECTOR: Pharmaceuticals & Drugs  1.93 L   1.06 K   145

31085.00
+109.50 (0.35%)
BSE: 12 Sep 04:01 PM

Price Summary

Today's High

₹ 31180

Today's Low

₹ 30875

52 Week High

₹ 35921.55

52 Week Low

₹ 25260.2

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

66053.46 Cr.

Enterprise Value

64425.54 Cr.

No. of Shares

2.12 Cr.

P/E

45.48

P/B

14.45

Face Value

₹ 10

Div. Yield

1.53 %

Book Value (TTM)

₹  2150.72

CASH

1627.92 Cr.

DEBT

0 Cr.

Promoter Holding

74.99 %

EPS (TTM)

₹  683.45

Sales Growth

9.58%

ROE

35.98 %

ROCE

47.87%

Profit Growth

17.75 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Abbott India Ltd.

BRUFEN Digene DUPHALAC Zolfresh Cremaffin Solspre Cremalax Ganaton LIBRAX THYROCAB Eptoin OBIMET SOLFE Wymox Thyronorm Duphaston Vertin Udiliv Heptral Prothiaden Stemetil Haemaccel Kenacort Paraxin Neomercazole Betonin Plus Syrup Arachitol Nano Ensure Similac

Index Presence

The company is present in 31Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year9.58%
3 Year9.26%
5 Year9.38%

Profit Growth

1 Year17.75%
3 Year20.99%
5 Year18.99%

ROE%

1 Year35.98%
3 Year34.45%
5 Year32.24%

ROCE %

1 Year47.87%
3 Year46.05%
5 Year43.24%

Debt/Equity

0

Price to Cash Flow

65.28

Interest Cover Ratio

166.0875

CFO/PAT (5 Yr. Avg.)

0.948160634370437

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 74.99 0.00
Mar 2025 74.99 0.00
Dec 2024 74.99 0.00
Sep 2024 74.99 0.00
Jun 2024 74.99 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 20.9855811793489% for the Past 3 years.
  • Company has been maintaining healthy ROE of 34.4493666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 46.0462% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 166.0875.
  • The Company has been maintaining an effective average operating margins of 22.7421781463403% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -46.6811 days.
  • Company has a healthy liquidity position with current ratio of 3.3695.
  • The company has a high promoter holding of 74.99%.

 Limitations

  • The company has shown a poor revenue growth of 9.26340837312298% for the Past 3 years.
  • The company is trading at a high PE of 45.48.
  • The company is trading at a high EV/EBITDA of 31.7325.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 1557.61 1632.67 1614.28 1604.59 1738.35
Total Expenditure 1166.6 1193.71 1178.19 1176.05 1292.76
Operating Profit 391.01 438.96 436.09 428.54 445.59
Other Income 67.33 60.48 71.75 76.02 72.84
Interest 2.75 2.5 2.26 3.92 5.82
Depreciation 18.37 17.51 17.99 17.93 19.48
Exceptional Items 0 0 0 0 0
Profit Before Tax 437.22 479.43 487.59 482.71 493.13
Tax 109.21 120.82 126.81 115.67 127.27
Profit After Tax 328.01 358.61 360.78 367.04 365.86
Adjusted EPS (Rs) 154.36 168.76 169.78 172.72 172.17

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 4310.02 4913.32 5348.73 5848.91 6409.15
Total Expenditure 3391.13 3831.74 4143.24 4395.86 4717.02
Operating Profit 918.89 1081.58 1205.49 1453.05 1692.13
Other Income 83.47 83.35 154.29 248.32 278.05
Interest 18.28 19.1 15.99 12.45 11.43
Depreciation 58.13 66.1 69.97 71.17 71.8
Exceptional Items 0 0 0 0 0
Profit Before Tax 925.95 1079.73 1273.82 1617.75 1886.95
Tax 235.26 281.03 324.41 416.53 472.51
Net Profit 690.69 798.7 949.41 1201.22 1414.44
Adjusted EPS (Rs.) 325.03 375.86 446.78 565.28 665.62

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 21.25 21.25 21.25 21.25 21.25
Total Reserves 2580.91 2798.54 3167.29 3677.64 4211.9
Borrowings 0 0 0 0 0
Other N/C liabilities 189.62 184.18 144.02 136.03 262.01
Current liabilities 1030.86 1203.19 1206.02 1342.72 1407.19
Total Liabilities 3822.64 4207.16 4538.58 5177.64 5902.35
Assets
Net Block 250.78 271 236.91 224.94 335.98
Capital WIP 0.66 0.66 3.66 10.11 18.08
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 78.8 79.35 97.88 80.18 74.9
Other N/C Assets 4.99 3.11 1175.02 1616.57 731.8
Current Assets 3487.41 3853.04 3025.11 3245.84 4741.59
Total Assets 3822.64 4207.16 4538.58 5177.64 5902.35
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 925.95 1079.73 1273.82 1617.75 1886.95
Adjustment 24.99 23.3 -62.7 -129.85 -164.63
Changes in Assets & Liabilities 11.26 133.62 23.13 129.38 -263.42
Tax Paid -235.46 -288.99 -340.86 -404.47 -447.06
Operating Cash Flow 726.74 947.66 893.39 1212.81 1011.84
Investing Cash Flow -71.82 -395.84 -147.71 -416.03 182.18
Financing Cash Flow -581.79 -637.38 -638.72 -744.71 -925.17
Net Cash Flow 73.13 -85.56 106.96 52.07 268.85

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 74.99 74.99 74.99 74.99 74.99
abbott capital india limi... 50.44 50.44 50.44 50.44 50.44
abbott healthcare product... 17.62 17.62 17.62 17.62 17.62
british colloids limited - 6.92 6.92 6.92 6.92
british colloids ltd 6.92 - - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 25.01 25.01 25.01 25.01 25.01
canara robeco mutual fund... 1.43 - 1.23 1.15 1.10
investor education and pr... - 0.54 - 0.53 0.53
sbi large & midcap fund - - - - 2.66
sbi retirement benefit fu... - - - 2.72 -
investor education and pr... 0.49 - 0.54 - -
sbi long term advantage f... - - 2.76 - -
canara robeco mutual fund... - 1.26 - - -
sbi arbitrage opportuniti... 2.20 2.58 - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research ICICI Securities Limited

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Abbott India - Quaterly Results 12 Aug, 1:16 PM Abbott India - Quaterly Results 12 Aug, 1:16 PM Abbott India - Quaterly Results 12 Aug, 1:16 PM Abbott India informs about disclosure 1 Aug, 4:27 PM Abbott India informs about newspaper advertisement 29 Jul, 5:18 PM Abbott India informs about closure of trading window 26 Jun, 5:20 PM Abbott, MSD Pharmaceuticals enter into partnership 19 Jun, 2:12 PM Abbott India - Quaterly Results 15 May, 7:03 PM Abbott India - Quaterly Results 15 May, 7:03 PM Abbott India informs about resignation letter of SMP 16 Apr, 11:46 AM Abbott India informs about appointment of senior management personnel 16 Apr, 10:18 AM Abbott India informs about certificate 10 Apr, 4:44 PM Abbott India informs about clarification on news article 6 Mar, 2:18 PM Abbott India informs about resignation of CFO 27 Feb, 1:18 PM Abbott India informs about resignation of senior management personnel 20 Feb, 9:37 AM Abbott India informs about newspaper cuttings 6 Feb, 2:36 PM Abbott India informs about newspaper publication 6 Feb, 1:10 PM Abbott India - Quaterly Results 5 Feb, 1:25 PM Abbott India - Quaterly Results 5 Feb, 1:25 PM Abbott India - Quaterly Results 5 Feb, 1:25 PM Abbott India informs about change in management 3 Feb, 3:22 PM Abbott India submits board meeting intimation 28 Jan, 2:38 PM Abbott India informs about movement in SMP 21 Jan, 10:27 AM Abbott India informs about change in designation of SMP 16 Jan, 9:46 AM Abbott India informs about change in senior management personnel 3 Jan, 10:23 AM Abbott India informs about closure of trading window 23 Dec, 11:50 AM Abbott India launches Pneumococcal Conjugate Vaccine ‘PneumoShield 14’ 28 Nov, 4:30 PM Abbott India informs about issuance of duplicate share certificate 8 Nov, 5:13 PM Abbott India - Quaterly Results 7 Nov, 1:29 PM Abbott India - Quaterly Results 7 Nov, 1:29 PM Abbott India - Quaterly Results 7 Nov, 1:29 PM Abbott India informs about loss of share certificate 5 Nov, 3:17 PM Abbott India informs about change in management 18 Oct, 4:13 PM Abbott India informs about compliances-certificate 11 Oct, 4:24 PM Abbott India informs about trading window closure 26 Sep, 4:45 PM Abbott India signs patent license agreement with Takeda Pharmaceuticals 20 Sep, 9:21 AM Abbott India informs about updates 31 Aug, 11:35 AM Abbott India - Quaterly Results 7 Aug, 5:53 PM Abbott India - Quaterly Results 7 Aug, 5:53 PM Abbott India - Quaterly Results 7 Aug, 5:53 PM Abbott India informs about board meeting 30 Jul, 2:55 PM Abbott India informs about change in management 23 Jul, 1:05 PM Abbott India informs about resignation of director 11 Jun, 12:04 PM Abbott India - Quaterly Results 9 May, 6:36 PM Abbott India - Quaterly Results 9 May, 6:36 PM Abbott India informs about appointment of senior management personnel 12 Apr, 10:59 AM Abbott India informs about newspaper advertisement 27 Mar, 2:50 PM Abbott India informs about resignation of managing director 19 Mar, 12:16 PM Abbott India informs about change in senior management personnel 15 Mar, 3:31 PM Abbott India informs about change in directorate 13 Mar, 1:00 PM

Abbott India Stock Price Analysis and Quick Research Report. Is Abbott India an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Abbott India. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Abbott India has a PE ratio of 45.328647324688 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Abbott India has ROA of 25.5314% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Abbott India has a Current ratio of 3.3695.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Abbott India has a ROE of 35.9771%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Abbott India has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Abbott India has reported revenue growth of 9.5785% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Abbott India for the current financial year is 26.401784948082%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Abbott India is Rs 475 and the yield is 1.5281%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Abbott India is Rs 683.453. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Abbott India in Ticker for free. Also, one can get the intrinsic value of Abbott India by using Valuation Calculators, which are available with a Finology ONE subscription. 

Abbott India FAQs

Q1. What is Abbott India share price today?
Ans: The current share price of Abbott India is Rs 30980.

Q2. What is the market capitalisation of Abbott India?
Ans: Abbott India has a market capitalisation of Rs 65830.337596 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Abbott India?
Ans: The PE ratio of Abbott India is 45.328647324688 and the P/B ratio of Abbott India is 14.4044805094778, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Abbott India share?
Ans: The 52-week high share price of Abbott India is Rs 37000, and the 52-week low share price of Abbott India is Rs 25325.

Q5. Does Abbott India pay dividends?
Ans: Currently, Abbott India pays dividends. Dividend yield of Abbott India is around 1.5281%.

Q6. What are the face value and book value of Abbott India shares?
Ans: The face value of Abbott India shares is Rs 10, while the book value per share of Abbott India is around Rs 2150.7197. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Abbott India?
Ans: Abbott India has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Abbott India?
Ans: The ROE of Abbott India is 35.9771% and ROCE of Abbott India is 47.8661%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Abbott India a good buy for the long term?
Ans: The Abbott India long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Abbott India undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Abbott India appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Abbott India’s financials?
Ans: You can review Abbott India’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Abbott India

Abbott India Ltd. Financials: Check Share Price, Balance Sheet, Annual Report and Quarterly Results for Company Analysis

Abbott India Ltd. is a leading pharmaceutical company in India, providing a range of healthcare products and services. In this article, we will provide a comprehensive analysis of Abbott India Ltd. stock from a long-term investor's perspective. We will cover various topics such as share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, concall, transcripts, investor presentations, promoters, and shareholders.

Abbott India Ltd. Share Price:

Abbott India Ltd.'s share price is an important indicator of investor sentiment towards the company. The share price is influenced by various factors such as the company's financial performance, global economic conditions, and market sentiment. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s share price and identify any trends or patterns. The company's share price has shown a stable trend over the past few years, reflecting the company's strong fundamentals.

Abbott India Ltd. Balance Sheet:

Abbott India Ltd.'s balance sheet provides crucial information about its financial health. The company's assets include investments, receivables, and other assets, while liabilities include borrowings, payables, and other liabilities. Equity includes share capital, reserves, and surplus. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s balance sheet and identify any red flags. The company's balance sheet has shown a stable trend over the past few years, reflecting the company's strong financial position. 

Abbott India Balance Sheet Examination

Abbott India Share Capital Consistency

Abbott India's Share Capital has remained consistently at Rs 21.25 Cr. from March 2020 through March 2024, showcasing a stable equity structure without any further equity dilution or buybacks.

Abbott India Reserves Escalation

A significant increase in Abbott India's Total Reserves is observed, escalating from Rs 2,410.45 Cr. in March 2020 to Rs 3,677.64 Cr. by March 2024. This upswing mirrors the company's retained earnings and reflects its robustness in profit accumulation over time.

Abbott India Debt-Free Status

Notably, Abbott India stands as a debt-free enterprise during the observed period, with zero borrowings reported from March 2020 to March 2024. This indicates a risk-averse financial stance and a strong balance sheet.

Abbott India Asset Growth

A steady growth in Total Assets is noted, from Rs 3,532.41 Cr. in March 2020 to Rs 5,177.64 Cr. in March 2024, with a significant jump in Other Non-Current Assets, from Rs 5.38 Cr. to Rs 1,616.57 Cr., potentially indicating strategic long-term investments or asset acquisitions.

This analysis presents data from the Standalone Balance Sheet of Abbott India, aiming to provide a clear depiction of the company's financial standing as of March 2024 without making investment recommendations.

For investors and stock screeners, Abbott India’s strong reserves and debt-free position might be important factors to consider within the pharmaceutical sector amid market movements and sector performance.

Abbott India Ltd. Annual Report:

Abbott India Ltd. releases an annual report every year, which provides detailed information about the company's financial performance, strategic initiatives, and future plans. The annual report includes a letter from the Chairman, financial statements, and management discussion and analysis. Long-term investors can download Abbott India Ltd.'s annual report from our website and use it to make informed investment decisions. The annual report provides valuable insights into the company's operations and financial performance.

Abbott India Ltd. Dividend:

Abbott India Ltd. has a consistent dividend payout history. The company has been paying dividends regularly, reflecting the company's strong financial position. Long-term investors should consider this when evaluating Abbott India Ltd.'s stock. Our pre-built screening tools can be used to analyze the company's dividend history and identify any trends or patterns.

Abbott India Ltd. Quarterly Results:

Abbott India Ltd. releases its quarterly results every three months. The quarterly results provide information about the company's revenue, earnings, and expenses. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s quarterly results and identify any trends or patterns. The quarterly results are an important indicator of the company's financial health and performance.

Abbott India Ltd. Stock Price:

The stock price of Abbott India Ltd. is affected by various factors such as the company's financial performance, global economic conditions, and market sentiment. Long-term investors can use our pre-built screening tools to track Abbott India Ltd.'s stock price and identify potential buying opportunities. The stock price of Abbott India Ltd. has shown a stable trend over the past few years, reflecting the company's strong fundamentals.

Abbott India Ltd. Price Chart:

A price chart provides a visual representation of a company's stock price over a period of time. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s price chart and identify any trends or patterns. The price chart shows that the stock price of Abbott India Ltd. has shown a stable trend over the past few years, reflecting the company's strong fundamentals.

Abbott India Ltd. News:

Keeping up to date with the latest news about Abbott India Ltd. is important for investors. Our website provides the latest news about Abbott India Ltd. from various sources such as financial news websites and social media. Long-term investors can use this information to make informed investment decisions.

Abbott India Ltd. Concall:

Abbott India Ltd. holds conference calls with analysts and investors to discuss its financial performance and future plans. Long-term investors can listen to Abbott India Ltd.'s concall and use the information provided to make informed investment decisions. Our website provides information about upcoming concalls and links to listen to past concalls.

Abbott India Ltd. Transcripts:

Transcripts of Abbott India Ltd.'s concalls are available on our website. Long-term investors can download the transcripts and use them to analyze the company's financial performance and future plans. The transcripts provide valuable insights into the company's operations and financial performance.

Abbott India Ltd. Investor Presentations:

Abbott India Ltd. provides investor presentations on its website. These presentations provide information about the company's financial performance, strategic initiatives, and future plans. Long-term investors can download Abbott India Ltd.'s investor presentations from our website and use them to make informed investment decisions. The investor presentations provide valuable insights into the company's operations and financial performance.

Abbott India Ltd. Promoters:

Promoters are individuals or entities that have a significant stake in a company. Abbott India Ltd.'s promoters include Abbott Laboratories and Abbott Healthcare Pvt. Ltd. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s promoter holdings and identify any potential conflicts of interest. The promoter holdings of Abbott India Ltd. are relatively stable, which is a positive sign for long-term investors.

Abbott India Ltd. Shareholders:

Abbott India Ltd. has a large number of shareholders, including institutional investors and individual investors. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s shareholder base and identify any potential risks or opportunities. The shareholder base of Abbott India Ltd. is diverse, which is a positive sign for long-term investors.

Abbott India Ltd. Premium Features:

Our website provides premium features tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. These tools can help long-term investors make better investment decisions by providing more detailed insights into the company's financial performance and valuation.

Abbott India Limited ROCE

The Return on Capital Employed (ROCE) is a key indicator of a company's profitability and efficiency in utilizing its capital. Abbott India Limited ROCE provides an insight into the company's ability to generate profits from its capital investments. By analyzing this ratio, investors and analysts can assess the company's operational efficiency and profitability. You can find Abbott India Limited's ROCE data in the financials table or the ratio section on this page.

Abbott India Limited EBITDA

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is an important measure of a company's operating performance. By analyzing Abbott India Limited EBITDA, investors and analysts can evaluate the company's profitability without the impact of non-operating expenses and non-cash items. It provides a clear picture of the company's operational efficiency and cash flow generation. You can find Abbott India Limited's EBITDA data in the financials table or the ratio section on this page.

Abbott India Limited DPS

Dividends per Share (DPS) is a measure of the cash paid to shareholders for each share they own in Abbott India Limited. Analyzing Abbott India Limited DPS provides insights into the company's dividend policy and profitability. It is important for investors who seek steady income from their investments. You can find information on Abbott India Limited's DPS in the financials table or the ratio section on this page.

Abbott India Limited EPS

Earnings per Share (EPS) is a key financial metric that indicates the profitability of Abbott India Limited on a per-share basis. By analyzing Abbott India Limited EPS, investors can assess the company's profitability and compare it with other companies in the industry. EPS is an important measure for both growth investors and value investors. You can find Abbott India Limited's EPS data in the financials table or the ratio section on this page.

Read More
X